• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚医护人员中抗 SARS-CoV-2 抗体的高血清阳性率。

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.

机构信息

Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

出版信息

BMC Infect Dis. 2022 Mar 16;22(1):261. doi: 10.1186/s12879-022-07247-z.

DOI:10.1186/s12879-022-07247-z
PMID:35296265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8926102/
Abstract

BACKGROUND

COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a measure of HWs' exposure to the virus and could be used as a guide to the prevalence of SARS-CoV-2 in the community and valuable in combating COVID-19. This information is currently lacking in Ethiopia and other African countries. This study aimed to develop an in-house antibody testing assay, assess the prevalence of SARS-CoV-2 antibodies among Ethiopian high-risk frontline HWs.

METHODS

We developed and validated an in-house Enzyme-Linked Immunosorbent Assay (ELISA) for specific detection of anti-SARS-CoV-2 receptor binding domain immunoglobin G (IgG) antibodies. We then used this assay to assess the seroprevalence among HWs in five public hospitals located in different geographic regions of Ethiopia. From consenting HWs, blood samples were collected between December 2020 and February 2021, the period between the two peaks of COVID-19 in Ethiopia. Socio-demographic and clinical data were collected using questionnaire-based interviews. Descriptive statistics and bivariate and multivariate logistic regression were used to determine the overall and post-stratified seroprevalence and the association between seropositivity and potential risk factors.

RESULTS

Our successfully developed in-house assay sensitivity was 100% in serum samples collected 2- weeks after the first onset of symptoms whereas its specificity in pre-COVID-19 pandemic sera was 97.7%. Using this assay, we analyzed a total of 1997 sera collected from HWs. Of 1997 HWs who provided a blood sample, and demographic and clinical data, 51.7% were females, 74.0% had no symptoms compatible with COVID-19, and 29.0% had a history of contact with suspected or confirmed patients with SARS-CoV-2 infection. The overall seroprevalence was 39.6%. The lowest (24.5%) and the highest (48.0%) seroprevalence rates were found in Hiwot Fana Specialized Hospital in Harar and ALERT Hospital in Addis Ababa, respectively. Of the 821 seropositive HWs, 224(27.3%) of them had a history of symptoms consistent with COVID-19 while 436 (> 53%) of them had no contact with COVID-19 cases as well as no history of COVID-19 like symptoms. A history of close contact with suspected/confirmed COVID-19 cases is associated with seropositivity (Adjusted Odds Ratio (AOR) = 1.4, 95% CI 1.1-1.8; p = 0.015).

CONCLUSION

High SARS-CoV-2 seroprevalence levels were observed in the five Ethiopian hospitals. These findings highlight the significant burden of asymptomatic infection in Ethiopia and may reflect the scale of transmission in the general population.

摘要

背景

COVID-19 大流行对撒哈拉以南非洲的经济和医疗保健系统造成了毁灭性的影响。医护人员(HWs)作为医疗系统的主要参与者,由于其职业而处于更高的风险之中。基于血清学的 SARS-CoV-2 感染估计代表了 HWs 接触病毒的程度,可作为社区中 SARS-CoV-2 流行情况的指南,并有助于抗击 COVID-19。目前,埃塞俄比亚和其他非洲国家都缺乏此类信息。本研究旨在开发一种内部抗体检测试验,评估埃塞俄比亚高风险一线 HWs 中 SARS-CoV-2 抗体的流行率。

方法

我们开发并验证了一种内部酶联免疫吸附测定(ELISA),用于特异性检测抗 SARS-CoV-2 受体结合域免疫球蛋白 G(IgG)抗体。然后,我们使用该检测方法评估了位于埃塞俄比亚五个不同地理位置的公立医院中 HWs 的血清阳性率。在 2020 年 12 月至 2021 年 2 月期间(埃塞俄比亚 COVID-19 两次高峰之间),从同意的 HWs 中采集血样。使用基于问卷的访谈收集社会人口统计学和临床数据。使用描述性统计以及双变量和多变量逻辑回归来确定总体和分层后的血清阳性率以及血清阳性与潜在危险因素之间的关联。

结果

我们成功开发的内部检测方法在出现症状后两周采集的血清样本中的灵敏度为 100%,而在 COVID-19 大流行前血清中的特异性为 97.7%。使用该检测方法,我们分析了总共 1997 份来自 HWs 的血清。在 1997 名提供血液样本和人口统计学及临床数据的 HWs 中,51.7%为女性,74.0%没有与 COVID-19 相符的症状,29.0%有与 SARS-CoV-2 感染的疑似或确诊患者接触的病史。总体血清阳性率为 39.6%。在 Harar 的 Hiwot Fana 专科医院和 Addis Ababa 的 ALERT 医院中,血清阳性率最低(24.5%)和最高(48.0%)。在 821 名血清阳性的 HWs 中,有 224 名(27.3%)有与 COVID-19 相符的症状史,而有 436 名(超过 53%)没有与 COVID-19 病例接触,也没有 COVID-19 样症状史。与疑似/确诊 COVID-19 病例的密切接触与血清阳性相关(调整后的优势比(AOR)= 1.4,95%CI 1.1-1.8;p= 0.015)。

结论

在埃塞俄比亚的五家医院中观察到 SARS-CoV-2 血清阳性率很高。这些发现突显了埃塞俄比亚无症状感染的巨大负担,可能反映了普通人群中的传播规模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aead/8928669/61bd6acc3049/12879_2022_7247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aead/8928669/33c3762b87e9/12879_2022_7247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aead/8928669/61bd6acc3049/12879_2022_7247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aead/8928669/33c3762b87e9/12879_2022_7247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aead/8928669/61bd6acc3049/12879_2022_7247_Fig2_HTML.jpg

相似文献

1
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.埃塞俄比亚医护人员中抗 SARS-CoV-2 抗体的高血清阳性率。
BMC Infect Dis. 2022 Mar 16;22(1):261. doi: 10.1186/s12879-022-07247-z.
2
High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers.埃塞俄比亚医护人员中抗新冠病毒抗体的高血清阳性率
Res Sq. 2021 Jul 19:rs.3.rs-676935. doi: 10.21203/rs.3.rs-676935/v1.
3
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.伊朗 18 个城市一般人群和高风险职业人群中 SARS-CoV-2 抗体血清流行率:一项基于人群的横断面研究。
Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15.
4
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.喀麦隆雅温得医护人员在第一波 COVID-19 大流行后严重急性呼吸综合征冠状病毒 2 的高血清阳性率及相关因素。
Influenza Other Respir Viruses. 2024 Feb;18(2):e13239. doi: 10.1111/irv.13239.
5
Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.非特异性疾病症状工人中冠状病毒病(COVID-19)的血清流行率和特征。
BMC Infect Dis. 2022 May 20;22(1):481. doi: 10.1186/s12879-022-07461-9.
6
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.埃塞俄比亚霍瓦萨地区学龄儿童中的 SARS-CoV-2 感染和 mRNA 疫苗诱导的体液免疫。
Front Immunol. 2023 Jun 15;14:1163688. doi: 10.3389/fimmu.2023.1163688. eCollection 2023.
7
Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.意大利中部一所教学医院的卫生工作者(HWs)中 SARS-CoV-2 感染的流行率和诊断检测性能。
Int J Environ Res Public Health. 2020 Jun 19;17(12):4417. doi: 10.3390/ijerph17124417.
8
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.SARS-CoV-2 抗体检测在医护人员中的应用:三种市售抗体检测试剂盒的临床性能比较。
Microbiol Spectr. 2021 Oct 31;9(2):e0039121. doi: 10.1128/Spectrum.00391-21. Epub 2021 Sep 29.
9
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.加拿大艾伯塔省 COVID-19 大流行前两波期间 SARS-CoV-2 抗体的预疫苗阳性率。
Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18.
10
Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.使用新型 SARS-CoV-2 总抗体 ELISA 对明尼苏达州门诊患者和医护人员进行的 COVID-19 血清流行率初步测定。
Clin Biochem. 2021 Apr;90:15-22. doi: 10.1016/j.clinbiochem.2021.01.010. Epub 2021 Feb 1.

引用本文的文献

1
Population-based cross-sectional seroprevalence study of SARS-CoV-2 infection in urban residential areas in Ghana.加纳城市居民区中基于人群的SARS-CoV-2感染横断面血清流行率研究。
BMJ Public Health. 2025 Jun 23;3(1):e001994. doi: 10.1136/bmjph-2024-001994. eCollection 2025.
2
Antibody Responses to SARS-CoV-2 among Health Care Workers in North-Eastern Tanzania.坦桑尼亚东北部医护人员对新冠病毒的抗体反应
East Afr Health Res J. 2024;8(3):305-314. doi: 10.24248/eahrj.v8i3.799. Epub 2025 Jan 30.
3
Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2.

本文引用的文献

1
Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic.埃塞俄比亚城乡地区新冠病毒的流行情况:随机家庭血清学调查揭示了疫情第一波期间的传播水平。
EClinicalMedicine. 2021 May 7;35:100880. doi: 10.1016/j.eclinm.2021.100880. eCollection 2021 May.
2
Seroprevalence surveys in sub-Saharan Africa: what do they tell us?撒哈拉以南非洲地区的血清流行率调查:它们告诉了我们什么?
Lancet Glob Health. 2021 Jun;9(6):e724-e725. doi: 10.1016/S2214-109X(21)00092-9. Epub 2021 Mar 9.
3
Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Infection Be Protective?
用于检测抗SARS-CoV-2抗体的内部酶联免疫吸附测定(ELISA)和两种商业血清学检测方法的比较评估
Sci Rep. 2025 Apr 22;15(1):13853. doi: 10.1038/s41598-025-97050-y.
4
Tailoring COVID-19 Vaccination Strategies in High-Seroprevalence Settings: Insights from Ethiopia.在高血清流行率地区制定新冠疫苗接种策略:来自埃塞俄比亚的见解
Vaccines (Basel). 2024 Jul 5;12(7):745. doi: 10.3390/vaccines12070745.
5
SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic.SARS-CoV-2 血清阳性率在大流行第三年的贝宁孕妇中。
BMC Public Health. 2024 Jul 2;24(1):1762. doi: 10.1186/s12889-024-19087-4.
6
Seroprevalence of SARS-CoV-2 and Hepatitis B Virus Coinfections among Ethiopians with Acute Leukemia.埃塞俄比亚急性白血病患者中新冠病毒2型与乙肝病毒合并感染的血清流行率
Cancers (Basel). 2024 Apr 22;16(8):1606. doi: 10.3390/cancers16081606.
7
Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity.对埃塞俄比亚新冠病毒血清流行率和变异株的长期监测可为免疫和交叉免疫提供预测。
Nat Commun. 2024 Apr 24;15(1):3463. doi: 10.1038/s41467-024-47556-2.
8
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.喀麦隆雅温得医护人员在第一波 COVID-19 大流行后严重急性呼吸综合征冠状病毒 2 的高血清阳性率及相关因素。
Influenza Other Respir Viruses. 2024 Feb;18(2):e13239. doi: 10.1111/irv.13239.
9
Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.医护人员中 SARS-CoV-2 感染的血清流行率及相关因素:横断面研究。
BMC Infect Dis. 2023 Nov 6;23(1):761. doi: 10.1186/s12879-023-08760-5.
10
Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.刚果(布) 2022 年 2 月 SARS-CoV-2 抗体血清阳性率。
Epidemiol Infect. 2023 Sep 11;151:e162. doi: 10.1017/S0950268823001425.
撒哈拉以南非洲地区的 COVID-19 轻症病例较少:合并感染或近期感染史是否具有保护作用?
Front Immunol. 2021 Feb 18;12:565625. doi: 10.3389/fimmu.2021.565625. eCollection 2021.
4
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.市售 SARS-CoV-2 IgG ELISA 在非洲来源血清样本中的特异性有限。
Trop Med Int Health. 2021 Jun;26(6):621-631. doi: 10.1111/tmi.13569. Epub 2021 Apr 5.
5
High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo.布卡武(刚果民主共和国东部城市)医护人员中高 SARS-CoV-2 血清流行率。
Am J Trop Med Hyg. 2021 Feb 16;104(4):1526-1530. doi: 10.4269/ajtmh.20-1526.
6
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2.SARS-CoV 结构蛋白抗体对 SARS-CoV-2 的交叉反应性。
Cell Rep. 2021 Feb 16;34(7):108737. doi: 10.1016/j.celrep.2021.108737. Epub 2021 Jan 26.
7
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.医护人员中 SARS-CoV-2 抗体的血清流行率及相关因素:系统评价和荟萃分析。
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
8
SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria.尼日利亚伊巴丹市无症状一线卫生工作者中 SARS-CoV-2 血清阳性率。
Am J Trop Med Hyg. 2021 Jan;104(1):91-94. doi: 10.4269/ajtmh.20-1235.
9
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.撒哈拉以南非洲地区存在严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)血清学交叉反应的高流行率。
Int J Infect Dis. 2021 Jan;102:577-583. doi: 10.1016/j.ijid.2020.10.104. Epub 2020 Nov 8.
10
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.COVID-19 患者血清和唾液中针对 SARS-CoV-2 刺突抗原的抗体反应持续存在。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe5511.